Literature DB >> 2198960

Cytokine regulation of the human burst-forming unit-megakaryocyte.

R A Briddell1, R Hoffman.   

Abstract

The human burst-forming unit-megakaryocyte (BFU-MK) is a primitive megakaryocytic progenitor cell. A marrow cell population enriched for BFU-MK (CD34+ DR-) was obtained by monoclonal antibody labeling and fluorescence-activated cell sorting. CD34+DR- cells were assayed in a serum-depleted, fibrin clot culture system. Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF), recombinant interleukin-3 (rIL-3), and megakaryocyte colony-stimulating factor (MK-CSF), partially purified from human plasma, were each individually capable of promoting BFU-MK-derived colony formation. Recombinant erythropoietin, rG-CSF, rIL-4, rIL-6, and thrombocytopiesis stimulating factor, partially purified from human embryonic kidney cell conditioned media, had no stimulatory effect on BFU-MK-derived colony formation when added alone or in various combinations with either GM-CSF, IL-3, or MK-CSF, GM-CSF and IL-3, GM-CSF and MK-CSF, but not IL-3 and MK-CSF had additive actions in promoting BFU-MK-derived colony formation, rIL-1 alpha had no influence alone on BFU-MK cloning efficiency, but had a dose-dependent, synergistic effect with IL-3, but not with GM-CSF or MK-CSF. The synergistic relationship between IL-1 alpha and IL-3 was abrogated by addition of an IL-1 alpha neutralizing antibody but not by a GM-CSF neutralizing antiserum, suggesting that IL-1 alpha acts directly on the BFU-MK and not by stimulating marrow auxiliary cells to secondarily release additional cytokines. Information presented here indicates that the regulatory influence, acting on the different stages of megakaryocyte development, are stage-specific and accomplished by multiple cytokines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2198960

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Cytokine production by a megakaryocytic cell line.

Authors:  B Sandrock; K M Hudson; D E Williams; M A Lieberman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-04       Impact factor: 2.416

2.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

3.  Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase.

Authors:  Alexia Eliades; Nikolaos Papadantonakis; Ajoy Bhupatiraju; Kelley A Burridge; Hillary A Johnston-Cox; Anna Rita Migliaccio; John D Crispino; Hector A Lucero; Philip C Trackman; Katya Ravid
Journal:  J Biol Chem       Date:  2011-06-10       Impact factor: 5.157

4.  Retroviral mediated gene transfer in megakaryocytic cell lines.

Authors:  W R Kiffmeyer; P J Stambrook; M A Lieberman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-11       Impact factor: 2.416

5.  Cytokine release by human bone marrow cells: analysis at the single cell level.

Authors:  D Rohde; C Wickenhauser; S Denecke; A Stach; J Lorenzen; M L Hansmann; J Thiele; R Fischer
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

6.  Impaired T cell signal transduction through CD28 in a patient with idiopathic thrombocytopenia.

Authors:  M Pérez-Blas; A Arnaiz-Villena; R Góngora; O G Segurado; J L Vivanco; J R Regueiro
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

7.  Acute side effects of homologous interleukin-3 in rhesus monkeys.

Authors:  F C van Gils; A H Mulder; C van den Bos; H Burger; R W van Leen; G Wagemaker
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

8.  Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors.

Authors:  M W Long; J A Robinson; E A Ashcraft; K G Mann
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.